Filing Details
- Accession Number:
- 0001209191-16-129868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-28 15:17:39
- Reporting Period:
- 2016-06-24
- Filing Date:
- 2016-06-28
- Accepted Time:
- 2016-06-28 15:17:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180469 | Ernest Mario | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-24 | 50,000 | $3.70 | 381,440 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2016-06-24 | 9,000 | $0.00 | 9,000 | $3.73 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2016-06-24 | 9,634 | $0.00 | 9,634 | $3.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,000 | 2026-06-23 | No | 4 | A | Direct | |
9,634 | 2026-06-23 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.6399 to $3.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2017 annual stockholder meeting.